{
    "nctId": "NCT06085833",
    "briefTitle": "ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions",
    "officialTitle": "ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions (ANGEL)",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 2706,
    "primaryOutcomeMeasure": "ARTIDIS as a sensitive diagnostic tool",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients aged \u2265 18 years\n* Ability to understand and the willingness to sign a written informed consent.\n* Indication for breast biopsy for diagnostic purposes\n* ECOG performance status of 0 to 3.\n\nExclusion Criteria:\n\n* Conditions that, in the investigator's opinion, might indicate that the subject is not suitable for the study.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}